SPC523
Neratíníb / Neratinib
Status:
UmsóknApplication date:
12.8.2025Application published:
1.9.2025
Medicine name:
NerlynxMedicine for children:
No
Timeline
Today
12.8.2025Application
1.9.2025Publication
Marketing license
IS authorization number:
EU/1/18/1311Date:
12.6.2023
Foreign authorization number:
EU/1/18/1311Date:
31.8.2018
Owner
Name:
Wyeth LLCAddress:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP4066821